-->

Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesAug 11, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 8, 2006View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionAug 3, 2006View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventAug 2, 2006View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 2, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 1, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 14, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 5, 2006View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 27, 2006View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 16, 2006View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 15, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 15, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 2, 2006View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 1, 2006View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMay 22, 2006View HTMLDownload DOCDownload PDF
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")May 16, 2006View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMay 12, 2006View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMay 12, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 9, 2006View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionMay 4, 2006View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMay 3, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 3, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 3, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 3, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 3, 2006View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-93

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information